The urinary tract is the second most common site of bacterial infection after the respiratory tract. Enterobacteria remain the first cause of urinary tract infections (UTIs), followed by staphylococci and non-fermenter bacteria. Furthermore, bacteria producing extended spectrum beta-lactamases (ESBL) have become more frequent, exposing African patients to therapeutic dead ends. The aim of this study was to determine the epidemiological profile of UTIs diagnosed at the Institut Pasteur in Bangui (IPB), Central African Republic (CAR), a research center that carries out antibiotic sensitivity testing according to international standards. For that, the collected demographic, clinical and biological data come from patients calling at the IPB for a urinalysis and who gave their consent for their data to be included and analyzed in this six-month cross-sectional study (January-June 2019). A total of 412 patients were enrolled in this study. The mean age was 35.2 years [1-80], females made up 55.8% of the study population and the sex ratio was 0.79:1 (M: F). Overall, 117 UTIs were detected, giving a prevalence rate of 28.4%. Of the bacterial isolates, 89.8% (105/117) were enterobacteria, of which 52.4% (55/105) were ESBL-producers. <i>Escherichia coli</i> accounted for more than half of the isolates 55.5% (65/117) and the ESBL-producers 58.2% (32/55). The 0–15-year age group showed the highest incidence of UTIs, but this rate was not significantly different from the other age groups (P = 0.665). Antecedent UTI was not a significant factor in the observed infections. However, female gender, fever, painful urination, acquisition in a healthcare setting and samples collected outside the laboratory were all significantly associated with UTI cases (P<0.005). The high proportion of ESBL-producing bacteria found during this study poses a real potential threat for public health in the CAR. Controlling antibiotic use should thus be a priority for the Ministry of Health.